Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation

Clinical Cancer Research

Volumn 10, Issue 22, 2004, Pages 7712-7720

  Kobayashi, Hisataka ^a   Reijnders, Koen ^a   English, Sean ^a   Yordanov, Alexander T ^a   Milenic, Diane E ^a   Sowers, Anastasia L ^a   Citrin, Deborah ^a   Krishna, Murali C ^a   Waldmann, Thomas A ^a   Mitchell, James B ^a   Brechbiel, Martin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; CD31 ANTIGEN; CONTRAST MEDIUM; DENDRIMER; GADOLINIUM; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; TUMOR VOLUME;

AMINES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOVASCULARIZATION, PATHOLOGIC; NYLONS; TIME FACTORS;

EID: 9344229794     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1175     Document Type: Article

References (62)

1. Folkman J, Klagsbrun M. Angiogenic factors. Science (Wash DC) 1987;235:442-7.
2. Kimura H, Braun RD, Ong ET, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996;56:5522-8.
3. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80.
4. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 2000;6:157-62.
5. Shirakawa K, Kobayashi H, Heike Y, et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 2002;62:560-6.
6. Peterson HI, Appelgren L. Tumour vessel permeability and transcapillary exchange of large molecules of different size. Bibl Anat 1977;15: 262-5.
7. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271:58-65.
8. Brown JM. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 2002;1:453-8.
9. Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 1981;41:73-81.
10. Yokota T, Milenic DE, Whitlow M, Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992;52:3402-8.
11. Saga T, Neumann RD, Heya T, et al. Targeting cancer micrometastases with monoclonal antibodies: A binding-site barrier. Proc Natl Acad Sci USA 1996;92:8999-9003.
12. Potchen EJ, Kinzie J, Curtis C, Siegal BA, Studer RK. Effect of irradiation on tumor microvascualture permeability to macro molecules. Cancer (Phila) 1972;30:639-42.
13. Rubin P, Casarett G. Microcirculation of tumors: the supervascualized state of irradiated regressing tumors. Clin Radiol 1966;17:346-55.
14. Song CW, Levitt SH. Vascular changes in Walker 256 carcinoma of rats following × irradiation. Radiobiol 1971;100:397-407.
15. Msirikale JS, Klein JL, Schroeder J, Order SE. Radiation enhancement of radiolabelled antibody deposition in tumors. Int J Radiat Oncol Biol Phys 1987;13:1839-44.
16. Stickney DR, Gridley DS, Kirk GA, Slater JM. Enhancement of monoclonal antibody (Mab) binding to melanoma with single dose radiation or hyperthermia. Cancer Drug Del 1985;2:225.
17. Sun LQ, Vogel CA, Mirimanoff RO, et al. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice. Cancer Res 1997;57:1312-9.
18. Ruan S, O'Donoghue JA, Larson SM, et al. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam. J Nucl Med 2000;41:1905-12.
19. Maraveyas A, Myers M, Stafford N, Rowlinson-Busza G, Stewart JS, Epenetos AA. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom for the larynx for radiation dose calculation to local tissues. Cancer Res 1995;55:1020-7.
20. Johansson A, Eriksson D, Ullen A, et al. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody. Cancer (Phila) 2002;94: 1314-9.
21. Kobayashi H, Sato N, Hiraga A, et al. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties. Magn Reson Med 2001;45:454-60.
22. Kobayashi H, Kawamoto S, Saga T, et al. Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents. J Magn Reson Imaging 2001;14:705-13.
23. Yordanov AT, Kobayashi H, English SJ, et al. Gadolinium-labeled dendrimers as biometric nanoprobes to detect vascular permeability J Mater Chem 2003;13:1523-5.
24. Tomalia DA, Naylor AM, Goddard III WA. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 1990;29:138-75.
25. Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 1251-labelled polyamidoamine dendrimers in vivo. J Control Release 2000;65:133-48.
26. Kobayashi H, Kawamoto S, Saga T, et al. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core Magn Reson Med 2001;46:795-802.
27. Wu C, Brechbiel MW, Kozak RW, Gansow OA. Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging. Bioorg Med Chem Lett 1994;4:449-54.
28. Singh P, Moll III F, Lin SH, et al. Starburst dendrimers: enhanced performance and flexibility for immunoassays. Clin Chem 1994;40: 1845-9.
29. Barth RF, Adams DM, Soloway AH, Alam F, Darby MV. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. Bioconjug Chem 1994;5:58-66.
30. Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Bioconjug Chem 1999;10:103-11.
31. Kobayashi H, Sato N, Saga T, et al. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity. Eur J Nucl Med 2000;27:1334-9.
32. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000;34:148-55.
33. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
34. Verhoye M, van der Sanden BPJ, Rijken PFJW, et al. Assessment of the neovasculature permeability in glioma xenografts by dynamic T1 MRI with gadomer-17. Magn Reson Med 2002;47:305-13.
35. 90Y radioimmunotherapy. Bioconjugate Chem 1991;2:187-94.
36. Fu KK, DeGregorio MW, Phillips JW. Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation. NCI Monogr 1988;6:123-7.
37. Yuan F. Transvascular drug delivery in solid tumors. Semin Radiat Oncol 1998;8:164-75.
38. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
39. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-51.
40. Del Guerra A, Belcari N. Advances in animal PET scanners. Q J Nucl Med 2002;46:35-47.
41. Kobayashi H, Sato N, Kawamoto S, et al. 3D MR angiography of intratumoral vasculature using a macromolecular MR contrast agent. Magn Reson Med 2001;46:579-85.
42. Ross BD, Chenevert TL, Rehemtulla A. Magnetic resonance imaging in cancer research. Eur J Cancer 2002;38:2147-56.
43. Bulte JW, Duncan ID, Frank J. A. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002;22:899-907.
44. Cohen FM, Kuwatsuru R, Shames DM, et al. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol 1994;29:970-7.
45. Yu H, Su MY, Wang Z, Nalcioglu O. A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging. Rad Res 2002;158:152-8.
46. Hall EJ. Repair of radiation damage and the dose-rate effect. In: EJ. Hall (editor) Radiobiology for the radiologist. Philadelphia, PA: Lippincott Williams & Wilkins, 2000. pp. 67-90.
47. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95:4607-12.
48. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000; 60:4440-5.
49. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 1994;54:3352-6.
50. Buchegger F, Halpern SE, Sutherland RM, Schreyer M, Mach JP. In vitro and in vivo tumor models for studies of distribution of radiolabelled monoclonal antibodies and fragments, Nuklearmedizin 1986;25: 207-9.
51. Kobayashi H, Le N, Kim IS, et al. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points. Cancer Res 1999;59:422-30.
52. Slavin-Chiorini DC, Horan Hand PH, Kashmiri SVS, Calvo B, Zaremba S, Schlom J. Biologic properties of a CH2 domain-deleted recombinant immunoglobulin. Int J Cancer 1993;53:97-103.
53. Hu S, Shively L, Raubitschek A, et al. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 1996;56:3055-61.
54. Perisic O, Webb PA, Holliger P, Winter G, Williams RL. Crystal structure of a diabody, a bivalent antibody fragment. Structure 1994;2: 1217-26.
55. Adams GP, McCartney JE, Tai MS, et al. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-cerbB-2 single-chain Fv. Cancer Res 1993;53:4026-34.
56. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science (Wash DC) 2003;300:1155-9.
57. Vajkoczy P, Blum S, Lamparter M, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003;197: 1755-65.
58. Wu NZ, Ross BA, Gulledge C, Klitzman B, Dodge R, Dewhirst MW. Differences in leucocyte-endothelium interactions between normal and adenocarcinoma bearing tissues in response to radiation. Br J Cancer 1994:69:883-9.
59. Epstein AL, Mizokami MM, Li J, Hu P, Khawli LA. Identification of a protein fragment of interleukin 2 responsible for vasopermeability. J Natl Cancer Inst 2003;95:741-9.
60. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-80.
61. Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999;59:3374-8.
62. Znati CA, Rosenstein M, Boucher Y, Epperly MW, Bloomer WD, Jain RK. Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res 1996;56:964-8.